CD177 and neoplasm: The pathway “immunoregulatory interactions between a lymphoid and non-lymphoid cell” involves a number of cell surface receptors (e.g., NK cell inhibitory receptors [KIRs] and leukocyte immunoglobulin-like receptors [LILRs]) and cell adhesion molecules that are involved in the regulation of anti-tumor immunity (https://reactome.org/content/detail/R-HSA-198933).